• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于结构的化合物库定制用于高通量筛选:新型EphB4激酶抑制剂的发现

Structure-based tailoring of compound libraries for high-throughput screening: discovery of novel EphB4 kinase inhibitors.

作者信息

Kolb Peter, Kipouros Catherine Berset, Huang Danzhi, Caflisch Amedeo

机构信息

Department of Biochemistry, University of Zurich, CH-8057 Zurich, Switzerland.

出版信息

Proteins. 2008 Oct;73(1):11-8. doi: 10.1002/prot.22028.

DOI:10.1002/prot.22028
PMID:18384152
Abstract

High-throughput docking is a computational tool frequently used to discover small-molecule inhibitors of enzymes or receptors of known three-dimensional structure. Because of the large number of molecules in chemical libraries, automatic procedures to prune multimillion compound collections are useful for high-throughput docking and necessary for in vitro screening. Here, we propose an anchor-based library tailoring approach (termed ALTA) to focus a chemical library by docking and prioritizing molecular fragments according to their binding energy which includes continuum electrostatics solvation. In principle, ALTA does not require prior knowledge of known inhibitors, but receptor-based pharmacophore information (hydrogen bonds with the hinge region) is additionally used here to identify molecules with optimal anchor fragments for the ATP-binding site of the EphB4 receptor tyrosine kinase. The 21,418 molecules of the focused library (from an initial collection of about 730,000) are docked into EphB4 and ranked by force-field-based energy including electrostatic solvation. Among the 43 compounds tested in vitro, eight molecules originating from two different anchors show low-micromolar activity in a fluorescence-based enzymatic assay. Four of them are active in a cell-based assay and are potential anti-angiogenic compounds.

摘要

高通量对接是一种计算工具,常用于发现已知三维结构的酶或受体的小分子抑制剂。由于化学文库中的分子数量众多,用于筛选数百万化合物集合的自动化程序对于高通量对接很有用,并且对于体外筛选是必要的。在此,我们提出了一种基于锚定的文库定制方法(称为ALTA),通过根据包括连续静电溶剂化在内的结合能对接分子片段并对其进行优先级排序,从而聚焦化学文库。原则上,ALTA不需要已知抑制剂的先验知识,但此处额外使用基于受体的药效团信息(与铰链区的氢键)来识别具有用于EphB4受体酪氨酸激酶ATP结合位点的最佳锚定片段的分子。聚焦文库中的21,418个分子(来自约730,000个的初始集合)被对接至EphB4,并根据包括静电溶剂化在内的基于力场的能量进行排名。在体外测试的43种化合物中,源自两个不同锚定的8个分子在基于荧光的酶促测定中显示出低微摩尔活性。其中4个在基于细胞的测定中具有活性,并且是潜在的抗血管生成化合物。

相似文献

1
Structure-based tailoring of compound libraries for high-throughput screening: discovery of novel EphB4 kinase inhibitors.基于结构的化合物库定制用于高通量筛选:新型EphB4激酶抑制剂的发现
Proteins. 2008 Oct;73(1):11-8. doi: 10.1002/prot.22028.
2
High-throughput virtual screening using quantum mechanical probes: discovery of selective kinase inhibitors.高通量虚拟筛选量子力学探针:选择性激酶抑制剂的发现。
ChemMedChem. 2010 Jul 5;5(7):1007-14. doi: 10.1002/cmdc.201000085.
3
Structure-based optimization of potent and selective inhibitors of the tyrosine kinase erythropoietin producing human hepatocellular carcinoma receptor B4 (EphB4).基于结构的酪氨酸激酶促红细胞生成素产生性人肝癌受体B4(EphB4)强效和选择性抑制剂的优化。
J Med Chem. 2009 Oct 22;52(20):6433-46. doi: 10.1021/jm9009444.
4
Automatic and efficient decomposition of two-dimensional structures of small molecules for fragment-based high-throughput docking.用于基于片段的高通量对接的小分子二维结构的自动高效分解
J Med Chem. 2006 Dec 14;49(25):7384-92. doi: 10.1021/jm060838i.
5
Discovery of kinase inhibitors by high-throughput docking and scoring based on a transferable linear interaction energy model.基于可转移线性相互作用能模型的高通量对接和评分发现激酶抑制剂。
J Med Chem. 2008 Mar 13;51(5):1179-88. doi: 10.1021/jm070654j. Epub 2008 Feb 14.
6
The discovery of novel vascular endothelial growth factor receptor tyrosine kinases inhibitors: pharmacophore modeling, virtual screening and docking studies.新型血管内皮生长因子受体酪氨酸激酶抑制剂的发现:药效团建模、虚拟筛选与对接研究
Chem Biol Drug Des. 2007 Mar;69(3):204-11. doi: 10.1111/j.1747-0285.2007.00488.x.
7
Inhibitors of the tyrosine kinase EphB4. Part 1: Structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines.酪氨酸激酶EphB4的抑制剂。第1部分:基于结构的一系列2,4-双苯胺基嘧啶的设计与优化。
Bioorg Med Chem Lett. 2008 May 1;18(9):2776-80. doi: 10.1016/j.bmcl.2008.04.015. Epub 2008 Apr 10.
8
Discovery of tyrosine kinase inhibitors by docking into an inactive kinase conformation generated by molecular dynamics.通过对接分子动力学产生的非活性激酶构象发现酪氨酸激酶抑制剂。
ChemMedChem. 2012 Nov;7(11):1983-90. doi: 10.1002/cmdc.201200331. Epub 2012 Sep 13.
9
The design, annotation, and application of a kinase-targeted library.激酶靶向文库的设计、注释及应用
Methods Mol Biol. 2011;685:279-91. doi: 10.1007/978-1-60761-931-4_14.
10
Fragment based lead discovery of small molecule inhibitors for the EPHA4 receptor tyrosine kinase.基于片段的小分子抑制剂的发现,用于 EphA4 受体酪氨酸激酶。
Eur J Med Chem. 2012 Jan;47(1):493-500. doi: 10.1016/j.ejmech.2011.11.020. Epub 2011 Nov 18.

引用本文的文献

1
Discovery of YTHDF2 Ligands by Fragment-Based Design.基于片段设计发现YTHDF2配体。
ACS Bio Med Chem Au. 2025 Jun 27;5(4):753-765. doi: 10.1021/acsbiomedchemau.5c00099. eCollection 2025 Aug 20.
2
The Science and Art of Structure-Based Virtual Screening.基于结构的虚拟筛选的科学与艺术。
ACS Med Chem Lett. 2024 Mar 25;15(4):436-440. doi: 10.1021/acsmedchemlett.4c00093. eCollection 2024 Apr 11.
3
An investigation of binding interactions of tumor-targeted peptide conjugated polyphenols with the kinase domain of ephrin B4 and B2 receptors.
靶向肿瘤的肽共轭多酚与 Ephrin B4 和 B2 受体激酶结构域结合相互作用的研究。
Mol Divers. 2024 Apr;28(2):817-849. doi: 10.1007/s11030-023-10621-x. Epub 2023 Feb 27.
4
Identification of a BAZ2A Bromodomain Hit Compound by Fragment Joining.通过片段连接鉴定BAZ2A溴结构域命中化合物
ACS Bio Med Chem Au. 2021 Dec 15;1(1):5-10. doi: 10.1021/acsbiomedchemau.1c00016. Epub 2021 Jul 7.
5
Discovery of a novel kinase hinge binder fragment by dynamic undocking.通过动态去对接发现一种新型激酶铰链结合片段
RSC Med Chem. 2020 Mar 4;11(5):552-558. doi: 10.1039/c9md00519f. eCollection 2020 May 1.
6
NMR-Fragment Based Virtual Screening: A Brief Overview.NMR 片段虚拟筛选:简介。
Molecules. 2018 Jan 25;23(2):233. doi: 10.3390/molecules23020233.
7
EphB4: A promising target for upper aerodigestive malignancies.EphB4:上呼吸道恶性肿瘤有前途的治疗靶点。
Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):128-137. doi: 10.1016/j.bbcan.2018.01.003. Epub 2018 Jan 31.
8
PoLi: A Virtual Screening Pipeline Based on Template Pocket and Ligand Similarity.PoLi:一种基于模板口袋和配体相似性的虚拟筛选流程
J Chem Inf Model. 2015 Aug 24;55(8):1757-70. doi: 10.1021/acs.jcim.5b00232. Epub 2015 Aug 12.
9
Fragment-based docking: development of the CHARMMing Web user interface as a platform for computer-aided drug design.基于片段的对接:开发CHARMMing网络用户界面作为计算机辅助药物设计平台
J Chem Inf Model. 2014 Sep 22;54(9):2612-20. doi: 10.1021/ci500322k. Epub 2014 Sep 10.
10
Discovery of a novel chemotype of tyrosine kinase inhibitors by fragment-based docking and molecular dynamics.通过基于片段的对接和分子动力学发现新型酪氨酸激酶抑制剂化学类型
ACS Med Chem Lett. 2012 Aug 23;3(10):834-8. doi: 10.1021/ml3001984. eCollection 2012 Oct 11.